Osteoblast response to zirconia-hybridized pyrophosphate-stabilized amorphous calcium phosphate

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 3, 2006, Pages 596-604

  Whited, Bryce M ^a   Skrtic, Drago ^b   Love, Brian J ^a,c   Goldstein, Aaron S ^a,c  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^c State University   (United States)

Author keywords

Alkaline phosphatase; Amorphous phosphate; Hydroxyapatite; MC3T3 E1 osteoblasts; Osteopontin

Indexed keywords

AMORPHOUS MATERIALS; CERAMIC MATERIALS; COLLAGEN; HYDROXYAPATITE; PH EFFECTS; ZIRCONIA;

ALKALINE PHOSPHATASE; AMORPHOUS PHOSPHATE; MC3T3-E1 OSTEOBLASTS; OSTEOPONTIN;

CALCIUM COMPOUNDS;

ALKALINE PHOSPHATASE; CALCIUM ION; CALCIUM PHOSPHATE; COLLAGEN; HYDROXYAPATITE; MINERAL; OSTEOPONTIN; PHOSPHATE; PYROPHOSPHATE; ZIRCONIUM OXIDE;

ADHESION; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; BONE PROSTHESIS; CALVARIA; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; CERAMICS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; IN VITRO STUDY; ION TRANSPORT; MINERALIZATION; MOLECULAR STABILITY; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; PH; PHYSICAL CHEMISTRY; PROTEIN SYNTHESIS; SOLUBILITY; SYNTHESIS;

ANIMALS; BONE SUBSTITUTES; CALCIUM PYROPHOSPHATE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; MATERIALS TESTING; MICE; OSTEOBLASTS; OSTEOGENESIS; SKULL; ZIRCONIUM;

EID: 33645296068     PISSN: 00219304     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30573     Document Type: Article

References (46)

1. Bohner M. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements. Injury 2000;31(Suppl 4):37-47.
2. Eggli PS, Muller W, Schenk RK. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the chancellors bone of rabbits. A comparative histomorphometric and histologic study of bony ingrowth and implant substitution. Clin Orthop Relat Res 1988;232:127-138.
3. Saffar JL, Colombier ML, Detienville R. Bone formation in tricalcium phosphate-filled periodontal intrabony lesions. Histological observations in humans. J Periodontol 1990;61:209-216.
4. Schmitz JP, Hollinger JO, Milam SB. Reconstruction of bone using calcium phosphate bone cements: A critical review. J Oral Maxillofac Surg 1999;57:1122-1126.
5. Goshima J, Goldberg VM, Caplan AI. Osteogenic potential of culture-expanded rat marrow cells as assayed in vivo with porous calcium phosphate ceramic. Biomaterials 1991;12:253-258.
6. Harris CT, Cooper LF. Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis. J Biomed Mater Res A 2004;68:747-755.
7. Lossdorfer S, Schwartz Z, Lohmann CH, Greenspan DC, Ranly DM, Boyan BD. Osteoblast response to bioactive glasses in vitro correlates with inorganic phosphate content. Biomaterials 2004;25:2547-2555.
8. Tenenbaum HC, Heersche JN. Differentiation of osteoblasts and formation of mineralized bone in vitro. Calcif Tissue Int 1982;34:76-79.
9. Chang YL, Stanford CM, Keller JC. Calcium and phosphate supplementation promotes bone cell mineralization: Implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res 2000;52:270-278.
10. Maeno S, Niki Y, Matsumoto H, Morioka H, Yatabe T, Funayama A, Toyama Y, Taguchi T, Tanaka J. The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. Biomaterials 2005;26:4847-4855.
11. Eanes ED. Amorphous calcium phosphate: Thermodynamic and kinetic considerations. In: Amjed Z, editor. Calcium Phosphates in Biological and Industrial Processes. Boston, MA: Kluwer Academic; 1998. p 21-40.
12. ter Brugge PJ, Wolke JG, Jansen JA. Effect of calcium phosphate coating composition and crystallinity on the response of osteogenic cells in vitro. Clin Oral Implants Res 2003;14:472-480.
13. Maxian SH, Zawadsky JP, Dunn MG. In vitro evaluation of amorphous calcium phosphate and poorly crystallized hydroxyapatite coatings on titanium implants. J Biomed Mater Res 1993;27:111-117.
14. Skrtic D, Antonucci JM, Eanes ED, Brunworth RT. Silica- and zirconia-hybridized amorphous calcium phosphate: Effect on transformation to hydroxyapatite. J Biomed Mater Res 2002;59:597-604.
15. Skrtic D, Antonucci JM, Eanes ED, Eidelman N. Dental composites based on hybrid and surface-modified amorphous calcium phosphates. Biomaterials 2004;25:1141-1150.
16. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture-An in vitro model of osteoblast development. J Bone Miner Res 1992;7:683-692.
17. Franceschi RT, Iyer BS. Relationship between collagen synthesis and expression of the osteoblastic phenotype in MC3T3-E1 cells. J Bone Miner Res 1992;7:235-246.
18. Lian JB, Stein GS. Concepts of osteoblast growth and different iation-Basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 1992;3:269-305.
19. Hauschka PV, Wians FH. Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone. Anat Rec 1989;224:180-188.
20. Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986;83:8819-8823.
21. Eanes ED, Gillesen H, Posner AS. Intermediate states in the precipitation of hydroxyapatite. Nature 1965;208:365-367.
22. Skrtic D, Antonucci JM, Eanes ED. Amorphous calcium phosphate-based bioactive polymeric composites for mineral tissue regeneration. J Res Natl Inst Stand Technol 2003;108:167-182.
23. Antonucci JM, Skrtic D. Matrix resin effects on selected physicochemical properties of amorphous calcium phosphate composites. J Bioact Compat Polym 2005;20:29-49.
24. Porter RM, Huckle WR, Goldstein AS. Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem 2003;90:13-22.
25. Badami AS, Kreke MR, Thompson MS, Riffle JS, Goldstein AS. Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials. 2006;27:596-606.
26. Goldstein AS, Juarez TM, Helmke CD, Gustin MC, Mikos AG. Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials 2001;22:1279-1288.
27. Kreke MR, Huckle WR, Goldstein AS. Fluid flow stimulates expression of osteopontin and bone sialoprotein by bone marrow stromal cells in a temporally dependent manner. Bone 2005;36:1047-1055.
28. Ishaug SL, Yaszemski MJ, Bizios R, Mikos AG. Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res 1994;28:1445-1453.
29. Massas R, Pitaru S, Weinreb MM. The effects of titanium and hydroxyapatite on osteoblastic expression and proliferation in rat parietal bone cultures. J Dent Res 1993;72:1005-1008.
30. Oonishi H. Orthopaedic applications of hydroxyapatite. Biomaterials 1991;12:171-178.
31. Ozawa S, Kasugai S. Evaluation of implant materials (hydroxyapatite, glass-ceramics, titanium) in rat bone marrow stromal cell culture. Biomaterials 1996;17:23-29.
32. Vrouwenvelder WC, Groot CG, de Groot K. Histological and biochemical evaluation of osteoblasts cultured on bioactive glass, hydroxylapatite, titanium alloy, and stainless steel. J Biomed Mater Res 1993;27:465-475.
33. Yamaguchi DT, Huang JT, Ma D. Regulation of gap junctional intercellular communication by pH in MC3T3-E1 osteoblastic cells. J Bone Miner Res 1995;10:1891-1899.
34. Schiller PC, D'Ippolito G, Balkan W, Roos BA, Howard GA. Gap-junctional communication is required for the maturation process of osteoblastic cells in culture. Bone 2001;28:362-369.
35. Radin S, Ducheyne P, Berthold P, Decker S. Effect of serum proteins and osteoblasts on the surface transformation of a calcium phosphate coating: A physicochemical and ultrasound study. J Biomed Mater Res 1998;39:234-243.
36. Li P, Ducheyne P. Quasi-biological apatite film induced by titanium in a simulated body fluid. J Biomed Mater Res 1998;41:341-348.
37. Areva S, Paldan H, Peltola T, Narhi T, Jokinen M, Linden M. Use of sol-gel-derived titania coating for direct soft tissue attachment. J Biomed Mater Res A 2004;70:169-178.
38. Evans EJ. Toxicity of hydroxyapatite in vitro: The effect of particle size. Biomaterials 1991;12:574-576.
39. Alliot-Licht B, Gregoire M, Orly I, Menanteau J. Cellular activity of osteoblasts in the presence of hydroxyapatite: An in vitro experiment. Biomaterials 1991;12:752-756.
40. Bushinsky DA. Metabolic alkalosis decreases bone calcium efflux by suppressing osteoclasts and stimulating osteoblasts. Am J Physiol 1996;271:F216-F222.
41. Denhardt DT, Noda M. Osteopontin expression and function: Role in bone remodeling. J Cell Biochem Suppl 1998;30-31:92-102.
42. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 1993;22:147-159.
43. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996;317:59-64.
44. Park EK, Lee YE, Choi JY, Oh SH, Shin HI, Kim KH, Kim SY, Kim S. Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrow-derived stromal cells. Biomaterials 2004;25:3403-3411.
45. Oreffo RO, Driessens FC, Planell JA, Triffitt JT. Growth and differentiation of human bone marrow osteoprogenitors on novel calcium phosphate cements. Biomaterials 1998;19:1845-1854.
46. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001;414:118-121.